Recurrent cholestasis following ovarian hyperstimulation syndrome: case report.
This is a case report illustrating a patient who developed recurrent cholestasis during a twin pregnancy following in-vitro fertilization (IVF) treatment. On the first occasion cholestasis developed unusually in the first trimester, and on the second occasion, it presented in the way that obstetric cholestasis (OC) is commonly seen in the third trimester.
Midgley
D Y
DY
Division of Women's and Children's Health, Guy's, King's and St Thomas's School of Medicine, London, UK.
Khalaf
Y
Y
Braude
P R
PR
Nelson-Piercy
C
C
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002585:Cesarean Section; D002779:Cholestasis / Q000209:etiology*; D005260:Female; D005307:Fertilization in Vitro; D005865:Gestational Age; D006801:Humans; D007741:Labetalol / Q000627:therapeutic use; D008111:Liver Function Tests; D008750:Methyldopa / Q000627:therapeutic use; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications; D011272:Pregnancy, Multiple; D012008:Recurrence; D014427:Twins
D000959:Antihypertensive Agents; D008750:Methyldopa; D007741:Labetalol